Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ionpath logo — Enabling precision medicine through high-definition spatial...

Ionpath

Enabling precision medicine through high-definition spatial proteomics

Founded 2014 United States Menlo Park, United States 32 employees Corporate Round Total: $18.00M Biotechnology, Health Care

General Information

Company Name Ionpath
Founded Year 2014
Location United States Menlo Park, United States +1
Employees 32
Industries Biotechnology, Health Care
Funding Stage Corporate Round
Social

Get notified when Ionpath moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ionpath

Ionpath has developed advanced ion beam imaging technology to revolutionize cancer diagnosis, with the aim of contributing to the improvement of human health. This innovation enables the precise examination of tissue biopsies, surpassing the capabilities of light microscopy. By catering to various tissue states, including fresh, frozen, or FFPE, Ionpath's technology significantly enhances the capability of healthcare providers to diagnose cancer effectively. Established in 2014, Ionpath operates within the Biotechnology and Health Care industries. Their commitment to innovation and impact is evident from their recent Corporate Round investment on 11 May 2022, with Thermo Fisher Scientific being their investing partner. Overall, Ionpath's cutting-edge technology and strategic partnerships position the company as a promising player in the healthcare industry, with potential for significant impact and growth.

Taxonomy: medical imaging, ion beam technology, cancer diagnosis, tissue analysis, biopsy technology, precision medicine, biomedical technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round •••••• 1 •••• •••• 11 May 2022
Series B •••••• 9
Investor Investor Investor Investor Investor Investor
•••• •••• 		24 Sep 2020
Series A •••••• - 20 Jan 2018
Seed Round •••••• - 01 Oct 2015

Ionpath Alternatives & Competitors

Ionpath vs
EMIT Imaging
EMIT Imaging United States

Industry-leading CFT instrument & services provider: 3D imaging tool to monitor drug distribution an...

Debt Financing
21 employees
Biotechnology
Compare Ionpath vs EMIT Imaging
Ionpath vs
TissueVision, Inc
TissueVision, Inc United States

TissueVision Inc. (TVI) is a multi-disciplinary life sciences company offering 3D tissue imaging and...

7 employees
Analytics, Biotechnology
Compare Ionpath vs TissueVision, Inc
Ionpath vs
Cell IDx
Cell IDx United States

Context Matters

Series Unknown
2 employees
Biotechnology, Information Technology
Compare Ionpath vs Cell IDx

FAQ About Ionpath

Enabling precision medicine through high-definition spatial proteomics
Ionpath was founded in 2014.
Ionpath is headquartered in Menlo Park, United States.
Ionpath operates in the following industries: Biotechnology, Health Care.
Ionpath has approximately 32 employees.
Ionpath has completed 4 funding rounds, raising a total of $18.00M. The latest funding stage is Corporate Round.
Top alternatives and competitors to Ionpath include EMIT Imaging, TissueVision, Inc, Cell IDx, Intek Scientific Inc., NanoString Technologies, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ionpath and EMIT Imaging are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ionpath and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy